Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 12;14(1):25.
doi: 10.3390/antib14010025.

Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy?

Han Sean Lee  1 , Henry H L Wu  2 , Arvind Ponnusamy  3   4 , Helen Alderson  1   4 , Rajkumar Chinnadurai  1   4
Affiliations
Review

Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy?

Han Sean Lee et al. Antibodies (Basel). .

Abstract

Diabetic nephropathy (DN) is one of the key causes of end-stage kidney disease worldwide, especially in developed countries. The classic pathogenic development of DN is characterized by microalbuminuria which would progress to nephrotic-range proteinuria and loss of kidney function. The degree of albuminuria is considered an independent risk factor for all-cause mortality in patients with DN. It is now well established that albuminuria stems from disruptions in podocyte structure and function. Podocytes play a major role in the glomerular filtration barrier. The nephrin protein has been identified as a core component of the slit diaphragm in podocytes, and as such, the downregulation of nephrin expression has been described well in various proteinuric glomerulopathies, including DN. Previous studies have shown that the presence of urinary nephrin potentially signifies an early marker of podocyte injury in DN. More recently, there have been increasing bodies of evidence which suggest that circulating autoantibodies targeting nephrin contributes to the pathogenesis of podocytopathies. However, the functional significance of these circulating autoantibodies in patients with DN is not well understood. In this review, we aim to evaluate the significance of nephrin dysregulation in the pathogenesis of DN based on the current available literature and provide an overview on the application of circulating anti-nephrin autoantibodies in relation to its diagnostic as well as prognostic role in podocytopathies, including DN.

Keywords: anti-nephrin; diabetes mellitus; diabetic nephropathy; diagnostic biomarker; nephrin; prognostic biomarker.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Pathogenesis of albuminuria in diabetic nephropathy.
Figure 2
Figure 2
Currently postulated roles of nephrin and anti-nephrin autoantibodies in the pathophysiology of diabetes mellitus and proteinuric glomerulopathies including diabetic nephropathy (mRNA = messenger ribonucleic acid) [10,11,12,13,15,16,22,27].
See this image and copyright information in PMC

References

    1. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102:S1–S127. doi: 10.1016/j.kint.2022.06.008. - DOI - PubMed
    1. Fangel M.V., Nielsen P.B., Kristensen J.K., Larsen T.B., Overvad T.F., Lip G.Y., Jensen M.B. Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study. Am. J. Med. 2020;133:e269–e279. doi: 10.1016/j.amjmed.2019.10.042. - DOI - PubMed
    1. Pasternak M., Liu P., Quinn R., Elliott M., Harrison T.G., Hemmelgarn B., Lam N., Ronksley P., Tonelli M., Ravani P. Association of Albuminuria and Regression of Chronic Kidney Disease in Adults with Newly Diagnosed Moderate to Severe Chronic Kidney Disease. JAMA Netw. Open. 2022;5:e2225821. doi: 10.1001/jamanetworkopen.2022.25821. - DOI - PMC - PubMed
    1. Heyman S.N., Raz I., Dwyer J.P., Weinberg Sibony R., Lewis J.B., Abassi Z. Diabetic Proteinuria Revisited: Updated Physiologic Perspectives. Cells. 2022;11:2917. doi: 10.3390/cells11182917. - DOI - PMC - PubMed
    1. Liu X.M., Wang Q., Dong Z.Y., Zhang W.G., Cai G.Y., Zhang L., Wang Y., Zhu H.Y., Tang L., Shen W.J., et al. Clinicopathological Features of Nondiabetic Renal Diseases from Different Age Groups: An Observational Cross-sectional Study. Chin. Med. J. 2018;131:2953–2959. doi: 10.4103/0366-6999.247197. - DOI - PMC - PubMed

LinkOut - more resources